Food Standards Australia New Zealand (FSANZ) is calling for comment on an application to permit the use of a beta-casein protein preparation (BCPP1) as a food ingredient.
BCPP1 is produced by fermentation from a genetically modified (GM) strain of the yeast Komagataella phaffi. The yeast contains the gene for the beta-casein A2 protein from Bos taurus (cow).
BCPP1 is intended as an ingredient in foods such as dairy substitutes, protein beverages and baked goods.
Our safety assessment found no public health or safety concerns with the proposed use of the ingredient.
However, because beta‑casein is a known milk allergen, foods containing BCPP1 would not be suitable for people with a milk allergy. To help protect these consumers, FSANZ is proposing these foods be labelled with a mandatory allergen declaration for ‘milk’. Dairy substitutes and other foods represented as not containing milk, that contain BCPP1, would also be required to display a front-of-pack advisory statement.
Foods containing BCCP1 would also need to be labelled as 'genetically modified' if they contain novel DNA and/or novel protein.
To have your say on this application, visit the FSANZ Consultation Hub. Submissions close at 11.59 pm (AEST) 20 August 2026.
What happens to my feedback?
FSANZ will consider all feedback received through this submission process before deciding on whether to approve the application.
Submissions will be published to our website as soon as possible at the end of the public comment period.
More information
- How to make a submission
- Read the assessment documents: A1342 - Beta-casein protein preparation from GM Komagataella phaffii
- Genetically modified foods
Media contact
- 0401 714 265 (Australia)
- +61 401 714 265 (from New Zealand)